Insider Trading History of Kaye Edward M. Md

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kaye Edward M. Md since 2015. This trader's CIK number is 1522780. At the time of last reporting, Kaye Edward M. Md was the Officer of Stoke Therapeutics, Inc.. (stock ticker symbol STOK). Also see all insider trading activities at Stoke Therapeutics, Inc..

Note that in the past Kaye Edward M. MD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Stoke Therapeutics, Inc. (STOK) by Kaye Edward M. Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 STOK 0 $0 93,300 $1,630,522 88,000 $0
2024 STOK 0 $0 24,106 $234,999 83,591 $0
2023 STOK 0 $0 0 $0 20,000 $12,000
2022 STOK 0 $0 0 $0 15,000 $9,000
2020 STOK 0 $0 0 $0 10,000 $6,000
2020 STOK 0 $0 50,000 $2,750,000 50,000 $30,000

Yearly summary of insider trading at Cytokinetics Inc (CYTK) by Kaye Edward M. Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CYTK 0 $0 10,392 $454,515 0 $0
2022 CYTK 0 $0 11,428 $571,400 11,428 $99,995
2021 CYTK 0 $0 15,000 $675,000 15,000 $114,150
2020 CYTK 0 $0 20,000 $600,000 20,000 $152,200

Yearly summary of insider trading at Sarepta Therapeutics, Inc. (SRPT) by Kaye Edward M. Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 SRPT 0 $0 10,000 $410,000 35,461 $0
2016 SRPT 0 $0 89,088 $4,365,050 67,531 $512,399
2015 SRPT 800 $9,452 0 $0 0 $0


Insider trading activities at 3 companies by Kaye Edward M. Md:

1. Stoke Therapeutics, Inc. (STOK)

2. Cytokinetics Inc (CYTK)

3. Sarepta Therapeutics, Inc. (SRPT)

Table 1. Insider trading of Stoke Therapeutics, Inc. (STOK) by Kaye Edward M. Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-09-03 STOK Sale 45,996 20.13 925,853
2025-08-29 STOK Sale 1,029 20.00 20,580
2025-09-02 STOK Sale 14,860 20.14 299,265
2025-08-18 STOK Sale 12,126 18.24 221,153
2025-08-14 STOK Option Ex 26,250 .00 0
2025-03-18 STOK Sale 10,382 8.67 90,011
2025-03-19 STOK Sale 8,907 8.27 73,660
2025-03-15 STOK Option Ex 61,750 .00 0
2024-12-09 STOK Sale 6,786 12.99 88,156
2024-12-06 STOK Sale 6,170 12.78 78,840
2024-12-03 STOK Option Ex 26,500 .00 0
2024-12-01 STOK Option Ex 21,591 .00 0
2024-03-15 STOK Option Ex 35,500 .00 0
2024-03-19 STOK Sale 11,150 6.10 68,003
2023-03-27 STOK Option Ex 20,000 .60 12,000
2022-05-25 STOK Option Ex 15,000 .60 9,000
2020-12-30 STOK Option Ex 10,000 .60 6,000
2020-12-17 STOK Sale 19,806 60.00 1,188,360
2020-12-18 STOK Sale 5,194 60.00 311,640
2020-11-27 STOK Sale 12,152 50.00 607,600
2020-11-25 STOK Sale 12,848 50.00 642,400
2019-12-16 STOK Option Ex 50,000 .60 30,000

Table 2. Insider trading of Cytokinetics Inc (CYTK) by Kaye Edward M. Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-09-02 CYTK Sale 6,756 50.00 337,800
2025-06-05 CYTK Sale 3,636 32.10 116,715
2022-08-05 CYTK Option Ex 11,428 8.75 99,995
2022-08-05 CYTK Sale 11,428 50.00 571,400
2021-12-23 CYTK Sale 15,000 45.00 675,000
2021-12-23 CYTK Option Ex 15,000 7.61 114,150
2020-10-05 CYTK Option Ex 20,000 7.61 152,200
2020-10-05 CYTK Sale 20,000 30.00 600,000

Table 3. Insider trading of Sarepta Therapeutics, Inc. (SRPT) by Kaye Edward M. Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-08-03 SRPT Option Ex 35,461 .00 0
2017-07-20 SRPT Sale 10,000 41.00 410,000
2016-11-09 SRPT Option Ex 3,000 8.28 24,839
2016-09-22 SRPT Option Ex 40,179 8.28 332,682
2016-09-22 SRPT Sale 40,179 60.00 2,410,740
2016-09-19 SRPT Sale 24,352 50.00 1,217,600
2016-09-19 SRPT Option Ex 24,352 6.36 154,878
2016-09-14 SRPT Sale 24,557 30.00 736,710
2015-02-27 SRPT Buy 800 11.81 9,452

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kaye Edward M. Md (Officer of Stoke Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.